Home

ARJUN GOYAL

CIK 1861844 · last filed 2026-06-24

ARJUN GOYAL is a corporate insider who has filed 8 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for CNTA, was dated Jun 24, 2026. Across all open-market trades the lifetime net is +$20.9M, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

8

Lifetime Open-Market Net

$20.87M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Centessa Pharmaceuticals plc (CNTA) Delisted Director 0 $40.50 $0 $20.87M 8 2026-06-24

Recent Filings

8 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-24 Centessa Pharmaceuticals plc (CNTA) Delisted Disp (D) −462,585 $0 EDGAR
2025-06-24 Centessa Pharmaceuticals plc (CNTA) Delisted Grant (A) — $0 EDGAR
2025-05-19 Centessa Pharmaceuticals plc (CNTA) Delisted Buy (P) +462,585 $5.87M EDGAR
2024-06-27 Centessa Pharmaceuticals plc (CNTA) Delisted Grant (A) — $0 EDGAR
2023-06-23 Centessa Pharmaceuticals plc (CNTA) Delisted Grant (A) — $0 EDGAR
2022-07-05 Centessa Pharmaceuticals plc (CNTA) Delisted Grant (A) — $0 EDGAR
2021-07-06 Centessa Pharmaceuticals plc (CNTA) Delisted Grant (A) — $0 EDGAR
2021-06-04 Centessa Pharmaceuticals plc (CNTA) Delisted Mixed +3,931,818 $15.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.